These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 23946196)

  • 41. Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for
    Jacobsen H; Rajendran M; Choi A; Sjursen H; Brokstad KA; Cox RJ; Palese P; Krammer F; Nachbagauer R
    mBio; 2017 Sep; 8(5):. PubMed ID: 28928215
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Influenza surveillance in five consecutive seasons during post pandemic period: results from National Influenza Center, Turkey].
    Altaş AB; Bayrakdar F; Korukluoğlu G
    Mikrobiyol Bul; 2016 Jul; 50(3):401-17. PubMed ID: 27525396
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Seasonal influenza vaccines induced high levels of neutralizing cross-reactive antibody responses against different genetic group influenza A(H1N1)pdm09 viruses.
    Haveri A; Ikonen N; Kantele A; Anttila VJ; Ruotsalainen E; Savolainen-Kopra C; Julkunen I
    Vaccine; 2019 May; 37(20):2731-2740. PubMed ID: 30954308
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype.
    Walz L; Kays SK; Zimmer G; von Messling V
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29925654
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Molecular Basis for Antigenic Drift of Human A/H2N2 Influenza Viruses.
    Linster M; Schrauwen EJA; van der Vliet S; Burke DF; Lexmond P; Bestebroer TM; Smith DJ; Herfst S; Koel BF; Fouchier RAM
    J Virol; 2019 Apr; 93(8):. PubMed ID: 30700609
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge.
    Mooney AJ; Gabbard JD; Li Z; Dlugolenski DA; Johnson SK; Tripp RA; He B; Tompkins SM
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28931689
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vaccination strategies to protect children against seasonal and pandemic influenza.
    Rimmelzwaan GF; Bodewes R; Osterhaus AD
    Vaccine; 2011 Oct; 29(43):7551-3. PubMed ID: 21820479
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serological response to influenza A H1N1 vaccine (Pandemrix®) and seasonal influenza vaccine 2009/2010 in renal transplant recipients and in hemodialysis patients.
    Ott U; Sauerbrei A; Lange J; Schäfler A; Walther M; Wolf G; Wutzler P; Zell R; Krumbholz A
    Med Microbiol Immunol; 2012 Aug; 201(3):297-302. PubMed ID: 22350187
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evidence of cross-reactive immunity to 2009 pandemic influenza A virus in workers seropositive to swine H1N1 influenza viruses circulating in Italy.
    De Marco MA; Porru S; Cordioli P; Cesana BM; Moreno A; Calzoletti L; Bonfanti L; Boni A; Di Carlo AS; Arici C; Carta A; Castrucci MR; Donatelli I; Tomao P; Peri VM; Di Trani L; Vonesch N
    PLoS One; 2013; 8(2):e57576. PubMed ID: 23469029
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sera from Individuals with Narrowly Focused Influenza Virus Antibodies Rapidly Select Viral Escape Mutations
    Davis AKF; McCormick K; Gumina ME; Petrie JG; Martin ET; Xue KS; Bloom JD; Monto AS; Bushman FD; Hensley SE
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30045982
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antibodies against swine influenza virus neutralize the pandemic influenza virus A/H1N1.
    Tsukamoto M; Hiroi S; Adachi K; Kato H; Inai M; Konishi I; Tanaka M; Yamamoto R; Sawa M; Handharyani E; Tsukamoto Y
    Mol Med Rep; 2011; 4(2):209-14. PubMed ID: 21468553
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antibody responses against influenza A(H1N1)pdm09 virus after sequential vaccination with pandemic and seasonal influenza vaccines in Finnish healthcare professionals.
    Strengell M; Ikonen N; Ziegler T; Kantele A; Anttila VJ; Julkunen I
    Influenza Other Respir Viruses; 2013 May; 7(3):431-8. PubMed ID: 22913369
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Elicitation of Protective Antibodies against 20 Years of Future H3N2 Cocirculating Influenza Virus Variants in Ferrets Preimmune to Historical H3N2 Influenza Viruses.
    Allen JD; Jang H; DiNapoli J; Kleanthous H; Ross TM
    J Virol; 2019 Feb; 93(3):. PubMed ID: 30429350
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevalence and predictors for homo- and heterosubtypic antibodies against influenza a virus.
    Kohler I; Scherrer AU; Zagordi O; Bianchi M; Wyrzucki A; Steck M; Ledergerber B; Günthard HF; Hangartner L
    Clin Infect Dis; 2014 Nov; 59(10):1386-93. PubMed ID: 25139962
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The evolution of humoral immune responses to past and novel influenza virus strains gives evidence for antigenic seniority.
    Sicca F; Sakorafa E; de Jonge A; de Vries-Idema J; Zhou F; Cox RJ; Huckriede A
    Front Immunol; 2022; 13():987984. PubMed ID: 36119111
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Age Dependence and Isotype Specificity of Influenza Virus Hemagglutinin Stalk-Reactive Antibodies in Humans.
    Nachbagauer R; Choi A; Izikson R; Cox MM; Palese P; Krammer F
    mBio; 2016 Jan; 7(1):e01996-15. PubMed ID: 26787832
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Novel influenza vaccine M2SR protects against drifted H1N1 and H3N2 influenza virus challenge in ferrets with pre-existing immunity.
    Hatta Y; Boltz D; Sarawar S; Kawaoka Y; Neumann G; Bilsel P
    Vaccine; 2018 Aug; 36(33):5097-5103. PubMed ID: 30007825
    [TBL] [Abstract][Full Text] [Related]  

  • 58. H3N2 influenza virus infection induces broadly reactive hemagglutinin stalk antibodies in humans and mice.
    Margine I; Hai R; Albrecht RA; Obermoser G; Harrod AC; Banchereau J; Palucka K; García-Sastre A; Palese P; Treanor JJ; Krammer F
    J Virol; 2013 Apr; 87(8):4728-37. PubMed ID: 23408625
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of prior seasonal H3N2 influenza vaccination or infection on protection and transmission of emerging variants of influenza A(H3N2)v virus in ferrets.
    Houser KV; Pearce MB; Katz JM; Tumpey TM
    J Virol; 2013 Dec; 87(24):13480-9. PubMed ID: 24089569
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Human T-cells directed to seasonal influenza A virus cross-react with 2009 pandemic influenza A (H1N1) and swine-origin triple-reassortant H3N2 influenza viruses.
    Hillaire MLB; Vogelzang-van Trierum SE; Kreijtz JHCM; de Mutsert G; Fouchier RAM; Osterhaus ADME; Rimmelzwaan GF
    J Gen Virol; 2013 Mar; 94(Pt 3):583-592. PubMed ID: 23152369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.